Taiwan Biomaterial Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	203.27	96.57	72.84	127.31	41.67	18.08
Revenue Growth (YoY)	142.73%	32.59%	-42.79%	205.48%	130.56%	9.26%
Cost of Revenue	76.65	39.27	25.72	36.94	9.52	3.33
Gross Profit	126.62	57.31	47.12	90.37	32.15	14.74
Selling, General & Admin	42.9	37.46	38.57	32.79	23.46	20.57
Research & Development	24.51	31.08	22.78	32.12	65.41	59.28
Operating Expenses	67.41	68.54	61.35	64.91	88.87	79.85
Operating Income	59.21	-11.24	-14.23	25.46	-56.72	-65.11
Interest Expense	-0.76	-0.8	-0.87	-0.97	-1.03	-1.04
Interest & Investment Income	5.03	3.84	4.7	2.25	0.49	1.44
Currency Exchange Gain (Loss)	-7.6	3.67	0.27	6.67	-0.63	-0.74
Other Non Operating Income (Expenses)	0.99	2.04	1.1	0.34	10.48	10.08
EBT Excluding Unusual Items	56.88	-2.49	-9.03	33.76	-47.4	-55.37
Gain (Loss) on Sale of Assets	-	-	-	-	-0.04	0
Pretax Income	56.88	-2.49	-9.03	33.76	-47.44	-55.37
Income Tax Expense	-	-0.76	1.1	-	-	-
Net Income	56.88	-1.73	-10.13	33.76	-47.44	-55.37
Net Income to Common	56.88	-1.73	-10.13	33.76	-47.44	-55.37
Shares Outstanding (Basic)	42	42	42	41	33	33
Shares Outstanding (Diluted)	42	42	42	41	33	33
Shares Change (YoY)	0.08%	-	2.73%	23.90%	-	3.96%
EPS (Basic)	1.35	-0.04	-0.24	0.83	-1.44	-1.68
EPS (Diluted)	1.35	-0.04	-0.24	0.83	-1.44	-1.68
Free Cash Flow	69.63	14.74	-12.74	-6.36	-54.3	-194.25
Free Cash Flow Per Share	1.66	0.35	-0.30	-0.16	-1.65	-5.89
Dividend Per Share	-	-	-	0.200	-	-
Gross Margin	62.29%	59.34%	64.69%	70.99%	77.15%	81.57%
Operating Margin	29.13%	-11.63%	-19.53%	20.00%	-136.10%	-360.22%
Profit Margin	27.98%	-1.79%	-13.91%	26.52%	-113.84%	-306.31%
Free Cash Flow Margin	34.26%	15.26%	-17.49%	-5.00%	-130.31%	-1074.68%
EBITDA	70.83	0.99	-2.28	36.02	-51.8	-59.18
EBITDA Margin	34.84%	1.03%	-3.14%	28.29%	-124.29%	-
D&A For EBITDA	11.62	12.23	11.94	10.55	4.92	5.93
EBIT	59.21	-11.24	-14.23	25.46	-56.72	-65.11
EBIT Margin	29.13%	-11.63%	-19.53%	20.00%	-136.10%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.